Experiment 908815

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationANON:. (1990). DIDEMNIN B.. 15(1)
Amount utilized
Compound isolated
Disease43 PATIENTS WERE TREATED IN A PHASE I TRIAL. DOSE LIMITING TOXICITY WAS NAUSEA/VOMITING. RECOMMENDED SINGLE DOSE FOR PHASE II TRIAL WAS 2.67 MG PER SQ.M. WITHOUT PROPHYLACTIC ANTIEMETICS AND 3.47 MG PER SQ.M. WITH AN ANTIEMETIC.
Dose amountVAR
Number3
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE